Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

AACR news: ABT-627 inhibits ovarian carcinoma growth and angiogenesis

April 3, 2000

AstraZeneca presents new pyrimidine-based cyclin-dependent kinase inhibitors

April 3, 2000

Aptosyn clinical trial completes enrollment in children with FAP

April 3, 2000

Vion and the NCI to commence phase I trial of TAPET for advanced cancer patients

April 3, 2000

A-228839: synthesis of a new agent for blocking Ras function

March 31, 2000

Cell Therapeutics submits NDA for arsenic trioxide

March 31, 2000

Breast cancer trial of annamycin commenced by Aronex

March 31, 2000

UroGen awarded SBIR grant to support prostate cancer gene therapy product development

March 31, 2000

Phase I/II clinical trial data reported for MTC-DOX in liver cancer

March 31, 2000

Clinical trial of STR in Ewing's sarcoma initiated by NeoRx

March 30, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...